Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,486 | 416 | 460 | 507 | 434 |
| Income taxes - deferred | 51 | -929 | 417 | 232 | 347 |
| Accounts receivable | -3,041 | -2,951 | 5,243 | -2,524 | 1,372 |
| Other Working Capital | -1,809 | -1,728 | -478 | -2,166 | 2,770 |
| Other Operating Activity | 4,326 | 3,200 | -5,562 | 2,637 | -995 |
| Operating Cash Flow | $1,012 | $-1,991 | $80 | $-1,312 | $3,927 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,411 | -8,700 | 2,671 | 160 | -10,335 |
| Other Investing Activity | 0 | 6,754 | -6,754 | 0 | 0 |
| Investing Cash Flow | $-1,411 | $-1,946 | $-4,083 | $160 | $-10,335 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 413 | 3,127 | 4,694 | -567 | -541 |
| Financing Cash Flow | $413 | $3,127 | $4,694 | $-567 | $-541 |
| Exchange Rate Effect | -14 | 1 | 62 | -226 | 152 |
| Beginning Cash Position | 0 | 1,196 | 462 | 2,001 | 8,798 |
| End Cash Position | 0 | 0 | 1,196 | 462 | 2,001 |
| Net Cash Flow | $14 | $-811 | $691 | $-1,720 | $-6,949 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,012 | -1,991 | 80 | -1,312 | 3,927 |
| Capital Expenditure | -1,411 | -8,707 | N/A | -727 | -10,506 |
| Free Cash Flow | -399 | -10,698 | 80 | -2,040 | -6,579 |